MENU
BLRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
BioLineRx (BLRX) Ownership - Who owns BioLineRx?
Industry: @Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
2 HaMa’ayan Street
Phone
+972 86429100
Employees
79
Web
https://www.biolinerx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
22.49M
P/E Ratio
N/A
Total Cash
40.06M
Projected Growth
N/A
Total Debt
31.26M
Revenue
17.05M
Risk (Beta)
1.34
Dividend Yield
N/A
Total Cash/Share
0.48
Total Debt/Equity
N/A
Revenue/Share
0.29 USD as % of share price
Fundamentals
BLRX
Capitalization
22.5M
P/E Ratio
N/A
Risk (Beta)
1.34
Dividend Yield
N/A
Total Cash
40.1M
Total Cash/Share
0.48
Total Debt
31.3M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.29%
Revenue
17M
ROE
N/A
Book Value
14M
P/B Ratio
2.07
Cash Flow
N/A
Earnings
-0.45
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
34.4M
Current Ratio
1.61
Current Revenue Per Employee
68265.82
Dividends Per Share - Security
N/A
EBITDA
-24.93M
Float
N/A
Float - Current
N/A
Gross Income Margin
83.37
Revenue To Assets
-48.76
Shares Held By Institutions
2.48M
Shares Outstanding - Current
84.1M
Total Liabilities
50.6M
Total Volume MTD
N/A
Value
1
Gain YTD
-86.688
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical-stage biopharmaceutical development company
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
2 HaMa’ayan Street
Phone
+972 86429100
Employees
79
Web
https://www.biolinerx.com